Matches in SemOpenAlex for { <https://semopenalex.org/work/W2790025101> ?p ?o ?g. }
- W2790025101 abstract "Novel therapies are undergoing clinical trials, for example, the Hsp90 inhibitor, XL888, in combination with BRAF inhibitors for the treatment of therapy-resistant melanomas. Unfortunately, our data show that this combination elicits a heterogeneous response in a panel of melanoma cell lines including PDX-derived models. We sought to understand the mechanisms underlying the differential responses and suggest a patient stratification strategy. Thermal proteome profiling (TPP) identified the protein targets of XL888 in a pair of sensitive and unresponsive cell lines. Unbiased proteomics and phosphoproteomics analyses identified CDK2 as a driver of resistance to both BRAF and Hsp90 inhibitors and its expression is regulated by the transcription factor MITF upon XL888 treatment. The CDK2 inhibitor, dinaciclib, attenuated resistance to both classes of inhibitors and combinations thereof. Notably, we found that MITF expression correlates with CDK2 upregulation in patients; thus, dinaciclib would warrant consideration for treatment of patients unresponsive to BRAF-MEK and/or Hsp90 inhibitors and/or harboring MITF amplification/overexpression." @default.
- W2790025101 created "2018-03-29" @default.
- W2790025101 creator A5006847485 @default.
- W2790025101 creator A5008837353 @default.
- W2790025101 creator A5009315904 @default.
- W2790025101 creator A5024889166 @default.
- W2790025101 creator A5043239620 @default.
- W2790025101 creator A5049913121 @default.
- W2790025101 creator A5051159339 @default.
- W2790025101 creator A5056347352 @default.
- W2790025101 creator A5057409863 @default.
- W2790025101 creator A5068306677 @default.
- W2790025101 creator A5069526269 @default.
- W2790025101 creator A5071050237 @default.
- W2790025101 creator A5073527632 @default.
- W2790025101 creator A5077723901 @default.
- W2790025101 creator A5085623017 @default.
- W2790025101 creator A5090227920 @default.
- W2790025101 date "2018-03-01" @default.
- W2790025101 modified "2023-10-18" @default.
- W2790025101 title "Targeting <scp>CDK</scp> 2 overcomes melanoma resistance against <scp>BRAF</scp> and Hsp90 inhibitors" @default.
- W2790025101 cites W1561515482 @default.
- W2790025101 cites W1595732636 @default.
- W2790025101 cites W1696775091 @default.
- W2790025101 cites W1945938728 @default.
- W2790025101 cites W1966467063 @default.
- W2790025101 cites W1976979641 @default.
- W2790025101 cites W1980516263 @default.
- W2790025101 cites W1993251792 @default.
- W2790025101 cites W2003270776 @default.
- W2790025101 cites W2004295816 @default.
- W2790025101 cites W2015009944 @default.
- W2790025101 cites W2018872127 @default.
- W2790025101 cites W2032211985 @default.
- W2790025101 cites W2036237603 @default.
- W2790025101 cites W2036321220 @default.
- W2790025101 cites W2038264590 @default.
- W2790025101 cites W2038963685 @default.
- W2790025101 cites W2043058822 @default.
- W2790025101 cites W2046024621 @default.
- W2790025101 cites W2051807533 @default.
- W2790025101 cites W2051875203 @default.
- W2790025101 cites W2052005627 @default.
- W2790025101 cites W2053619668 @default.
- W2790025101 cites W2061061337 @default.
- W2790025101 cites W2062802357 @default.
- W2790025101 cites W2063955417 @default.
- W2790025101 cites W2078021348 @default.
- W2790025101 cites W2080752012 @default.
- W2790025101 cites W2082057045 @default.
- W2790025101 cites W2089158037 @default.
- W2790025101 cites W2092129054 @default.
- W2790025101 cites W2096237314 @default.
- W2790025101 cites W2098023402 @default.
- W2790025101 cites W2100614336 @default.
- W2790025101 cites W2103557568 @default.
- W2790025101 cites W2105660237 @default.
- W2790025101 cites W2106543129 @default.
- W2790025101 cites W2113432767 @default.
- W2790025101 cites W2128542677 @default.
- W2790025101 cites W2131321938 @default.
- W2790025101 cites W2140642045 @default.
- W2790025101 cites W2141674733 @default.
- W2790025101 cites W2152061559 @default.
- W2790025101 cites W2154853638 @default.
- W2790025101 cites W2155381255 @default.
- W2790025101 cites W2157918066 @default.
- W2790025101 cites W2160834915 @default.
- W2790025101 cites W2161275429 @default.
- W2790025101 cites W2164947531 @default.
- W2790025101 cites W2165091551 @default.
- W2790025101 cites W2168420784 @default.
- W2790025101 cites W2216761081 @default.
- W2790025101 cites W2253992243 @default.
- W2790025101 cites W2300290254 @default.
- W2790025101 cites W2424133004 @default.
- W2790025101 cites W2560367415 @default.
- W2790025101 cites W2560526401 @default.
- W2790025101 cites W2562236228 @default.
- W2790025101 cites W2580602149 @default.
- W2790025101 doi "https://doi.org/10.15252/msb.20177858" @default.
- W2790025101 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5836539" @default.
- W2790025101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29507054" @default.
- W2790025101 hasPublicationYear "2018" @default.
- W2790025101 type Work @default.
- W2790025101 sameAs 2790025101 @default.
- W2790025101 citedByCount "47" @default.
- W2790025101 countsByYear W27900251012018 @default.
- W2790025101 countsByYear W27900251012019 @default.
- W2790025101 countsByYear W27900251012020 @default.
- W2790025101 countsByYear W27900251012021 @default.
- W2790025101 countsByYear W27900251012022 @default.
- W2790025101 countsByYear W27900251012023 @default.
- W2790025101 crossrefType "journal-article" @default.
- W2790025101 hasAuthorship W2790025101A5006847485 @default.
- W2790025101 hasAuthorship W2790025101A5008837353 @default.
- W2790025101 hasAuthorship W2790025101A5009315904 @default.
- W2790025101 hasAuthorship W2790025101A5024889166 @default.
- W2790025101 hasAuthorship W2790025101A5043239620 @default.
- W2790025101 hasAuthorship W2790025101A5049913121 @default.